Ng IO - Search Results

1

Deleted in liver cancer 2 (DLC2) was dispensable for development and its deficiency did not aggravate hepatocarcinogenesis.

Yau TO, Leung TH, Lam S, Cheung OF, Tung EK, Khong PL, Lam A, Chung S, Ng IO. Yau TO, et al. Among authors: ng io. PLoS One. 2009 Aug 10;4(8):e6566. doi: 10.1371/journal.pone.0006566. PLoS One. 2009. PMID: 19668331 Free PMC article.

2

Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma.

Ching YP, Wong CM, Chan SF, Leung TH, Ng DC, Jin DY, Ng IO. Ching YP, et al. Among authors: ng io, ng dc. J Biol Chem. 2003 Mar 21;278(12):10824-30. doi: 10.1074/jbc.M208310200. Epub 2003 Jan 16. J Biol Chem. 2003. PMID: 12531887 Free article.

3

Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.

Wong CM, Yam JW, Ching YP, Yau TO, Leung TH, Jin DY, Ng IO. Wong CM, et al. Among authors: ng io. Cancer Res. 2005 Oct 1;65(19):8861-8. doi: 10.1158/0008-5472.CAN-05-1318. Cancer Res. 2005. PMID: 16204057 Free article.

4

Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity.

Leung TH, Ching YP, Yam JW, Wong CM, Yau TO, Jin DY, Ng IO. Leung TH, et al. Among authors: ng io. Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15207-12. doi: 10.1073/pnas.0504501102. Epub 2005 Oct 10. Proc Natl Acad Sci U S A. 2005. PMID: 16217026 Free PMC article.

5

Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression.

Yam JW, Ko FC, Chan CY, Jin DY, Ng IO. Yam JW, et al. Among authors: ng io. Cancer Res. 2006 Sep 1;66(17):8367-72. doi: 10.1158/0008-5472.CAN-05-2850. Cancer Res. 2006. PMID: 16951145

6

Tensin2 variant 3 is associated with aggressive tumor behavior in human hepatocellular carcinoma.

Yam JW, Ko FC, Chan CY, Yau TO, Tung EK, Leung TH, Jin DY, Ng IO. Yam JW, et al. Among authors: ng io. Hepatology. 2006 Oct;44(4):881-90. doi: 10.1002/hep.21339. Hepatology. 2006. PMID: 17006924

7

Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma.

Wong CC, Wong CM, Ko FC, Chan LK, Ching YP, Yam JW, Ng IO. Wong CC, et al. Among authors: ng io. PLoS One. 2008 Jul 23;3(7):e2779. doi: 10.1371/journal.pone.0002779. PLoS One. 2008. PMID: 18648664 Free PMC article.

8

Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function.

Chan LK, Ko FC, Ng IO, Yam JW. Chan LK, et al. Among authors: ng io. PLoS One. 2009;4(5):e5572. doi: 10.1371/journal.pone.0005572. Epub 2009 May 15. PLoS One. 2009. PMID: 19440389 Free PMC article.

9

Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.

Ko FC, Yeung YS, Wong CM, Chan LK, Poon RT, Ng IO, Yam JW. Ko FC, et al. Among authors: ng io. Liver Int. 2010 Jan;30(1):139-48. doi: 10.1111/j.1478-3231.2009.02133.x. Epub 2009 Oct 27. Liver Int. 2010. PMID: 19874489

10

Akt phosphorylation of deleted in liver cancer 1 abrogates its suppression of liver cancer tumorigenesis and metastasis.

Ko FC, Chan LK, Tung EK, Lowe SW, Ng IO, Yam JW. Ko FC, et al. Among authors: ng io. Gastroenterology. 2010 Oct;139(4):1397-407. doi: 10.1053/j.gastro.2010.06.051. Epub 2010 Jun 20. Gastroenterology. 2010. PMID: 20600027 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

440 results

Search Page

Filters